Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Bortezomib plus dexamethasone can improve stem cell collection and overcome the need for additional chemotherapy before autologous transplant in patients with myeloma.

Corso A, Barbarano L, Mangiacavalli S, Spriano M, Alessandrino EP, Cafro AM, Pascutto C, Varettoni M, Bernasconi P, Grillo G, Carella AM, Montalbetti L, Lazzarino M, Morra E.

Leuk Lymphoma. 2010 Feb;51(2):236-42. doi: 10.3109/10428190903452826.

PMID:
20001242
2.

Long-term outcome in relapsed and refractory multiple myeloma treated with thalidomide. Balancing efficacy and side-effects.

Corso A, Zappasodi P, Barbarano L, Petrucci MT, Palumbo A, Caravita T, Mangiacavalli S, Cafro AM, Varettoni M, Gay F, Morra E, Lazzarino M.

Leuk Res. 2009 Sep;33(9):e145-9. doi: 10.1016/j.leukres.2009.03.015. Epub 2009 Apr 16.

PMID:
19375164
3.

Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: definition and management of the risk related to zoledronic acid.

Cafro AM, Barbarano L, Nosari AM, D'Avanzo G, Nichelatti M, Bibas M, Gaglioti D, Taroni A, Riva F, Morra E, Andriani A.

Clin Lymphoma Myeloma. 2008 Apr;8(2):111-6. Erratum in: Clin Lymphoma Myeloma. 2008 Aug;8(4):260. Barbarano, Luciana [added]; Nosari, Anna Maria [added]; D'Avanzo, Giovanna [added]; Nichelatti, Michele [added]; Bibas, Michele [added]; Gaglioti, Domenico [added]; Taroni, Alberto [added]; Riva, Francesco [added]; Morra, Enrica [added]; Andriani, Alessand.

PMID:
18501105
4.

Low efficacy of thalidomide in improving response after induction in multiple myeloma patients who are candidates for high-dose therapy.

Corso A, Mangiacavalli S, Barbarano L, Montalbetti L, Mazzone A, Fava S, Varettoni M, Zappasodi P, Morra E, Lazzarino M.

Leuk Res. 2008 Jul;32(7):1085-90. Epub 2007 Dec 21.

PMID:
18096226
5.

Limited feasibility of double transplant in multiple myeloma: results of a multicenter study on 153 patients aged <65 years.

Corso A, Mangiacavalli S, Barbarano L, Alessandrino EP, Cairoli R, Morra E, Lazzarino M; HOST Group.

Cancer. 2007 Jun 1;109(11):2273-8.

6.

Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients.

Piana F, Codecasa LR, Cavallerio P, Ferrarese M, Migliori GB, Barbarano L, Morra E, Cirillo DM.

Eur Respir J. 2006 Jul;28(1):31-4. Epub 2006 Mar 15.

7.

Prognostic factors for transformation in asymptomatic immunoglobulin m monoclonal gammopathies.

Morra E, Cesana C, Klersy C, Barbarano L, Miqueleiz S, Varettoni M, Lucchesini C, Ricci F, Lazzarino M.

Clin Lymphoma. 2005 Mar;5(4):265-9.

PMID:
15794862
8.

Clinical characteristics and outcome of immunoglobulin M-related disorders.

Cesana C, Barbarano L, Miqueleiz S, Lucchesini C, Ricci F, Varettoni M, Filippini D, Lazzarino M, Morra E.

Clin Lymphoma. 2005 Mar;5(4):261-4.

PMID:
15794861
9.

The VAD-DCEP sequence is an effective pre-transplant therapy in untreated multiple myeloma.

Corso A, Barbarano L, Zappasodi P, Cairoli R, Alessandrino EP, Mangiacavalli S, Ferrari D, Fava S, Fiumanò M, Frigerio G, Isa L, Luraschi A, Klersy C, De Paoli A, Vergani C, Banfi L, Perego D, Ucci G, Pinotti G, Savarè M, Uziel L, Vismara A, Morra E, Lazzarino M.

Haematologica. 2004 Sep;89(9):1124-7.

10.

Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders.

Morra E, Cesana C, Klersy C, Barbarano L, Varettoni M, Cavanna L, Canesi B, Tresoldi E, Miqueleiz S, Bernuzzi P, Nosari AM, Lazzarino M.

Leukemia. 2004 Sep;18(9):1512-7.

PMID:
15322559
11.

Risk factors for the development of bacterial infections in multiple myeloma treated with two different vincristine-adriamycin-dexamethasone schedules.

Cesana C, Nosari AM, Klersy C, Miqueleiz S, Rossi V, Ferrando P, Valentini M, Barbarano L, Morra E.

Haematologica. 2003 Sep;88(9):1022-8.

12.

Predictive variables for malignant transformation in 452 patients with asymptomatic IgM monoclonal gammopathy.

Morra E, Cesana C, Klersy C, Varettoni M, Cavanna L, Canesi B, Tresoldi E, Barbarano L, Lazzarino M; Hematology/Oncology Studies and Trials (HOST) Group, Italy.

Semin Oncol. 2003 Apr;30(2):172-7.

PMID:
12720131
13.

Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocol.

Riccardi A, Mora O, Tinelli C, Porta C, Danova M, Brugnatelli S, Grasso D, Tolcà B, Spanedda R, De Paoli A, Barbarano L, Cavanna L, Giordano M, Delfini C, Nicoletti G, Bergonzi C, Rinaldi E, Piccinini L, Ascari E.

Eur J Cancer. 2003 Jan;39(1):31-7.

PMID:
12504655
14.

Efficacy of an early intensification treatment integrating chemotherapy, autologous stem cell transplantation and radiotherapy for poor risk primary mediastinal large B cell lymphoma with sclerosis.

Cairoli R, Grillo G, Tedeschi A, Gargantini L, Marenco P, Tresoldi E, Barbarano L, Nosari AM, Morra E.

Bone Marrow Transplant. 2002 Mar;29(6):473-7.

15.

Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.

Cesana C, Klersy C, Barbarano L, Nosari AM, Crugnola M, Pungolino E, Gargantini L, Granata S, Valentini M, Morra E.

J Clin Oncol. 2002 Mar 15;20(6):1625-34.

PMID:
11896113
16.

DCEP (dexamethasone, cyclophosphamide, etoposide, and cisplatin) is an effective regimen for peripheral blood stem cell collection in multiple myeloma.

Lazzarino M, Corso A, Barbarano L, Alessandrino EP, Cairoli R, Pinotti G, Ucci G, Uziel L, Rodeghiero F, Fava S, Ferrari D, Fiumanò M, Frigerio G, Isa L, Luraschi A, Montanara S, Morandi S, Perego D, Santagostino A, Savarè M, Vismara A, Morra E.

Bone Marrow Transplant. 2001 Nov;28(9):835-9.

17.

Long-term survival of stage I multiple myeloma given chemotherapy just after diagnosis or at progression of the disease: a multicentre randomized study. Cooperative Group of Study and Treatment of Multiple Myeloma.

Riccardi A, Mora O, Tinelli C, Valentini D, Brugnatelli S, Spanedda R, De Paoli A, Barbarano L, Di Stasi M, Giordano M, Delfini C, Nicoletti G, Bergonzi C, Rinaldi E, Piccinini L, Ascari E.

Br J Cancer. 2000 Apr;82(7):1254-60.

18.

Treatment of patients with high-grade non-Hodgkin's lymphoma aged over 70 years with an all-oral regimen combining idarubicin, etoposide and alkylators.

Morra E, Gargantini L, Nosari A, Barbarano L, Pungolino E, Santoleri L, Bernuzzi P.

Crit Rev Oncol Hematol. 2000 Aug;35(2):95-100.

PMID:
10936466
19.

Relevance of age on survival of 341 patients with multiple myeloma treated with conventional chemotherapy: updated results of the MM87 prospective randomized protocol. Cooperative Group of Study and Treatment of Multiple Myeloma.

Riccardi A, Mora O, Brugnatelli S, Tinelli C, Spanedda R, De Paoli A, Barbarano L, Di Stasi M, Bergonzi C, Giordano M, Delfini C, Nicoletti G, Rinaldi E, Piccinini L, Valentini D, Ascari E.

Br J Cancer. 1998;77(3):485-91.

20.

Oral idarubicin and prednisone for advanced, previously untreated, multiple myeloma: a pilot study. Cooperative Group of Study and Treatment of Multiple Myeloma.

Brugnatelli S, Riccardi A, Ucci G, Petrini M, Giordano M, Barbarano L, Bergonzi C, De Paoli A, Cavanna L, Ascari E.

Ann Oncol. 1996 Jul;7(5):537-8. No abstract available.

PMID:
8839915
21.

Experience with poorly myelosuppressive chemotherapy schedules for advanced myeloma. The Cooperative Group of Study and Treatment of Multiple Myeloma.

Brugnatelli S, Riccardi A, Ucci G, Mora O, Barbarano L, Piva N, Piccinini L, Bergonzi C, De Paoli A, Di Stasi M, Rinaldi E, Trotti G, Petrini M, Ascari E.

Br J Cancer. 1996 Mar;73(6):794-7.

22.
23.

A prospective, controlled, nonrandomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple-myeloma.

Riccardi A, Ucci G, Brugnatelli S, Mora O, Merlini G, Piva N, Depaoli A, Barbarano L, Distasi M, Alberio F, Nicoletti G, Morandi S, Rinaldi E, Piccinini L, Ascari E.

Int J Oncol. 1994 Oct;5(4):833-9.

PMID:
21559649
24.

Splenectomy for severe HIV-related thrombocytopenia in heroin abusers.

Landonio G, Nosari AM, Barbarano L, Muti G, Panzacchi G, Baudo F, Cipriani D, deCataldo F.

Br J Haematol. 1988 Jun;69(2):290. No abstract available.

PMID:
3390397
25.

Renal abnormalities reverted by plasma exchange in thrombotic thrombocytopenic purpura.

Dal Col A, Busnach G, Perrino ML, Barbarano L, Brando B, Rovati C, Minetti L.

Int J Artif Organs. 1983 Jul;6 Suppl 1:69-71.

PMID:
6685692
26.

[Clinical and biohumoral significance of plasma viscosity in patients with paraproteinemia without clinical hyperviscosity syndrome. A study of 40 cases (author's transl)].

Barbarano L, Rossi AF, Vendrami R, Van Westerhout G, Sala G, Canesi BA.

Haematologica. 1981 Aug;66(4):452-60. Italian. No abstract available.

PMID:
6797880
27.

Transcriptional and post-transcriptional defects in beta0-thalassaemia.

Comi P, Giglioni B, Barbarano L, Ottolenghi S, Williamson R, Novakova M, Masera G.

Eur J Biochem. 1977 Oct 3;79(2):617-22.

Supplemental Content

Loading ...
Support Center